Inventor · disambiguated record
Fariba Khanshan
Also filed as: KHANSHAN FARIBA
0 granted patents·3 pending applications·0 citations·filing 2020–2021
Files withNOVARTIS AG3
Top patents by PatentIndex Score
3 records- 0152US2023056470A1Uses of anti-tgf-beta antibodies and checkpoint inhibitors for the treatment of proliferative diseasesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0252US2023321067A1Dosing regimen comprising 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivativesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0349US2023057071A1Combination of anti tim-3 antibody mbg453 and anti tgf-beta antibody nis793, with or without decitabine or the anti pd-1 antibody spartalizumab, for treating myelofibrosis and myelodysplastic syndromeNOVARTIS AG·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fariba Khanshan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →